- Home
- WHLR vs ENSC Comparison
WHLR vs ENSC Comparison
Compare WHLR & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- ENSC
- Stock Information
- Founded
- WHLR 2011
- ENSC 2003
- Country
- WHLR United States
- ENSC United States
- Employees
- WHLR N/A
- ENSC N/A
- Industry
- WHLR Real Estate Investment Trusts
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- ENSC Health Care
- Exchange
- WHLR Nasdaq
- ENSC Nasdaq
- Market Cap
- WHLR 1.5M
- ENSC 4.9M
- IPO Year
- WHLR 2012
- ENSC N/A
- Fundamental
- Price
- WHLR $5.81
- ENSC $2.16
- Analyst Decision
- WHLR
- ENSC
- Analyst Count
- WHLR 0
- ENSC 0
- Target Price
- WHLR N/A
- ENSC N/A
- AVG Volume (30 Days)
- WHLR 2.9M
- ENSC 60.9K
- Earning Date
- WHLR 08-05-2025
- ENSC 08-13-2025
- Dividend Yield
- WHLR N/A
- ENSC N/A
- EPS Growth
- WHLR N/A
- ENSC N/A
- EPS
- WHLR N/A
- ENSC N/A
- Revenue
- WHLR $102,793,000.00
- ENSC $6,224,081.00
- Revenue This Year
- WHLR N/A
- ENSC N/A
- Revenue Next Year
- WHLR N/A
- ENSC $1,381.48
- P/E Ratio
- WHLR N/A
- ENSC N/A
- Revenue Growth
- WHLR 0.86
- ENSC 256.35
- 52 Week Low
- WHLR $3.33
- ENSC $1.62
- 52 Week High
- WHLR $10,567.20
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- WHLR 48.32
- ENSC 46.61
- Support Level
- WHLR $5.65
- ENSC $1.97
- Resistance Level
- WHLR $6.40
- ENSC $2.40
- Average True Range (ATR)
- WHLR 0.93
- ENSC 0.16
- MACD
- WHLR 0.21
- ENSC 0.00
- Stochastic Oscillator
- WHLR 11.09
- ENSC 44.19
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.